Which of the following is an adverse drug reaction associated with fremanezumab (Ajovy)?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

Which of the following is an adverse drug reaction associated with fremanezumab (Ajovy)?

Fremanezumab is a monoclonal antibody administered by subcutaneous injection for migraine prevention. A common adverse reaction seen with injectable biologics is local irritation at the injection site. Injection site reactions—such as redness, swelling, itching, or pain—occur frequently with fremanezumab and are usually mild and self-limited. While nausea, dizziness, and headache can occur with various therapies or as part of migraine itself, they are not as specifically linked to fremanezumab as injection site reactions.

Fremanezumab is a monoclonal antibody administered by subcutaneous injection for migraine prevention. A common adverse reaction seen with injectable biologics is local irritation at the injection site. Injection site reactions—such as redness, swelling, itching, or pain—occur frequently with fremanezumab and are usually mild and self-limited. While nausea, dizziness, and headache can occur with various therapies or as part of migraine itself, they are not as specifically linked to fremanezumab as injection site reactions.

More practice questions